For a person living with chronic limb-threatening ischemia, success has to mean more than an open artery. Relief from pain, the ability to move around, and the possibility of returning to daily life belong in the conversation from the beginning.
A new BEST-CLI conference abstract in Circulation brings that conversation into focus for patients with frailty. Its encouraging finding: patients with greater frailty reported improved quality of life after revascularization, even though their absolute quality-of-life scores remained lower.
What the analysis found
This post hoc analysis included 1,754 of the 1,830 BEST-CLI participants. Investigators examined quality-of-life outcomes after surgical or endovascular revascularization, with higher frailty defined by a frailty index of at least 0.45.
The reported pattern is clinically relevant: improvement and a persistent burden of illness can coexist. Patients with greater frailty could report gains without reaching the same quality-of-life level as less-frail participants.
The analysis did not identify a statistically significant interaction between frailty and treatment strategy. That finding does not establish that bypass and endovascular treatment are equivalent, or that either approach is right for every patient with frailty.
Why this matters for limb preservation
Frailty should sharpen the discussion about goals, recovery, and support. A label alone cannot tell us whether the outcome a patient values most is relief from rest pain, getting to the bathroom independently, returning home, or walking with family.
The practical question is how a proposed treatment fits that person’s life. Anatomy, available conduit, procedural risk, life expectancy, wound burden, and the patient’s preferences still need to be considered together. A quality-of-life signal adds another dimension to that discussion.
For the limb-preservation team, it is also a reason to ask more specific questions before treatment and during follow-up: What activity matters most to this person? What is preventing it now? What support would be needed if recovery is difficult?
Keep the limits in view
These are conference-abstract findings from a post hoc analysis, not a complete report of methods and results. The available abstract does not provide enough detail to assess fully how missing questionnaires and deaths affected the quality-of-life estimates.
BEST-CLI enrolled selected patients considered suitable for the trial’s revascularization strategies. These results should not be extended automatically to people with prohibitive procedural risk or those who would not have qualified for the trial.
There was also no untreated comparison group. Improvement observed after revascularization does not, by itself, establish how those same patients would have fared without it.
A more useful conversation
The study supports a thoughtful discussion of potential quality-of-life improvement in selected patients with frailty, alongside an honest account of risk and uncertainty. It does not support a blanket promise of benefit.
As we work to prevent amputation, we should keep asking what successful limb preservation would allow each person to do. That answer deserves a place beside the vascular images and the wound measurements.
#ActAgainstAmputation #LimbPreservation #BESTCLI #CLTI
Source
Frailty and Quality-of-Life Outcomes After Revascularization for Chronic Limb-Threatening Ischemia: A Post Hoc Analysis of the BEST-CLI Trial. Circulation. 2026;154(Suppl 1):A10034. Published November 2, 2026. doi:10.1161/circ.154.suppl_1.10034. Conference abstract.
Leave a Reply